Deutsche Bank Ag\ Evelo Biosciences, Inc. Transaction History

Deutsche Bank Ag\

  • $240 Billion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$1.46 - $3.55 $25,669 - $62,416
-17,582 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$2.66 - $6.63 $22,391 - $55,811
-8,418 Reduced 32.38%
17,582 $60,000
Q4 2021

Feb 11, 2022
SELL
$6.07 - $12.0 $66,478 - $131,424
-10,952 Reduced 29.64%
26,000 $158,000
Q3 2021

Nov 04, 2021
BUY
$6.79 - $13.9 $112,897 - $231,115
16,627 Added 81.81%
36,952 $260,000
Q2 2021

Aug 11, 2021
BUY
$9.43 - $16.6 $33,231 - $58,498
3,524 Added 20.97%
20,325 $280,000
Q1 2021

May 13, 2021
BUY
$9.71 - $18.6 $4,592 - $8,797
473 Added 2.9%
16,801 $179,000
Q4 2020

Feb 16, 2021
BUY
$3.91 - $12.28 $19,593 - $61,535
5,011 Added 44.28%
16,328 $198,000
Q3 2020

Nov 12, 2020
BUY
$3.81 - $5.73 $13,616 - $20,479
3,574 Added 46.16%
11,317 $60,000
Q2 2020

Aug 13, 2020
BUY
$3.53 - $6.12 $11,384 - $19,737
3,225 Added 71.38%
7,743 $38,000
Q1 2020

May 14, 2020
SELL
$3.21 - $7.06 $8,493 - $18,680
-2,646 Reduced 36.93%
4,518 $16,000
Q4 2019

Feb 14, 2020
BUY
$3.81 - $7.45 $13,144 - $25,702
3,450 Added 92.89%
7,164 $28,000
Q3 2019

Nov 14, 2019
SELL
$5.45 - $8.8 $42,673 - $68,904
-7,830 Reduced 67.83%
3,714 $21,000
Q2 2019

Aug 14, 2019
SELL
$6.52 - $9.42 $44,368 - $64,103
-6,805 Reduced 37.09%
11,544 $102,000
Q1 2019

May 15, 2019
BUY
$7.5 - $15.31 $2,257 - $4,608
301 Added 1.67%
18,349 $145,000
Q4 2018

Feb 14, 2019
BUY
$7.29 - $13.01 $42,981 - $76,706
5,896 Added 48.52%
18,048 $234,000
Q3 2018

Dec 21, 2021
BUY
$11.93 - $14.76 $16,809 - $20,796
1,409 Added 13.12%
12,152 $148,000
Q3 2018

Nov 14, 2018
BUY
$11.93 - $14.76 $5,595 - $6,922
469 Added 4.56%
10,743 $130,000
Q2 2018

Apr 21, 2020
BUY
$11.39 - $16.26 $19,829 - $28,308
1,741 Added 20.4%
10,274 $121,000
Q2 2018

Aug 14, 2018
BUY
$11.39 - $16.26 $97,190 - $138,746
8,533 New
8,533 $100,000

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email